Over the last 3 decades, Pseudomonas aeruginosa has become a leading cause of infectious morbidity and mortality in certain predisposed patient populations. It primarily affects those with impaired host defenses, and its prevalence in the hospital environment makes it an important nosocomial pathogen. Infection with this organism may result in a broad spectrum of clinical manifestations, many of which may be seen in the intensive care setting. This review focuses on epidemiology, clinical presentations, nad treatment of serious Pseudomonas infections.
Get full access to this article
View all access options for this article.
References
1.
GessardC.On the blue and green coloration that appears on bandages. Rev Infect Dis1984;6 (suppl 3):S775–S776.
2.
StanleyMM.Bacillus pyocyaneus infections: a review, report of cases and discussion of newer therapy including streptomycin (concluded). Am J Med19472: 347–367.
3.
StanleyMM.Bacillus pyocyaneus infections: a review, report of cases and discussion of newer therapy including streptomycin. Am J Med19472: 253–274.
4.
KerbyGP.Pseudomonas aeruginosa bacteremia: summary of literature with report of a case. Am J Dis Child194774: 610–615.
5.
JacobsRFMcCarthyREElserJM.Pseudomonas osteochon-dritis complicating puncture wounds of the foot in children: a 10-year evaluation. J Infect Dis1989160: 657–661.
6.
GustafsonTLBandJDHutchesonRHSchaffnerW.Pseudomonas folliculitis: an outbreak and review. Rev Infect Dis19835: 1–8.
7.
GilardiGL.Pseudomonas and related genera. In: BalowsAHausierWJJrHerrmannKL, eds. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1991429–441.
8.
KnirelYA.Polysaccharide antigens of Pseudomonas aeruginosa. CRC Crit Rev Microbiol199017: 273–304.
PollackM.Pseudomonas aeruginosa. In: MandellGLDouglasRGJrBennettJE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 1673–1691.
11.
RogersDE.The changing pattern of life-threatening microbial disease. N Engl J Med1959261: 677–683.
12.
FinlandMJonesFBarnesMW.Occurrence of serious bacterial infections since the introduction of antibacterial agents. JAMA1959170: 2188–2197.
13.
FinlandM.Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Ann Intern Med197276: 1009–1036.
14.
SchabergDRCulverDHGaynesRP.Major trends in the microbial etiology of nosocomial infection. Am J Med1991, 91 (suppl 3B):72S–75S.
15.
CrossAAllenJRBurkeJNosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis1983, 5 (suppl 5):S837–S845.
16.
MorrisonAJJrWenzelRP.Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis1984, 6 (suppl 3):S627–S642.
17.
WeinsteinRA.Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med1991, 91 (suppl 3B):179S–184S.
18.
BryanCSReynoldsKLBrennerER.Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis1983; 5:629–638.
19.
KregerBECravenDECarlingPCMcCabeWR.Gram-negative bacteremia: III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med1980; 68:332–343.
20.
FaveroMSCarsonLABondWWPetersenNJ.Pseudomonas aeruginosa: growth in distilled water from hospitals. Science1971; 173:836–838.
21.
TeresDSchweersPBushneilLSSources of Pseudomonas aeruginosa infection in a respiratory/surgical intensive-therapy unit. Lancet1973; 1:415–417.
22.
BodeyGPBolivarRFainsteinVJadejaL.Infections caused by Pseudomonas aeruginosa. Rev Infect Dis1983; 5: 279–313.
23.
WrightCKominosSDYeeRB.Enterobacteriaceae and Pseudomonas aeruginosa recovered from vegetable salads. Appl Environ Microbiol1976; 31:453–454.
24.
KominosSDCopelandCEGrosiakBPosticB.Introduction of Pseudomonas aeruginosa into a hospital via vegetables. Appl Microbiol197224: 567–570.
25.
RosenthalSTagerIB.Prevalence of gram-negative rods in the normal pharyngeal flora. Ann Intern Med197583: 355–357.
26.
SchimpffSCMoodyMYoungVM.Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients. In: HobbyGL, ed. Antimicrobial agents and chemotherapy—1970. Washington, DC: American Society for Microbiology, 1971:240–244.
27.
RamphaiRSadofJCPyleMSilipigniJD.Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium. Infect Immun1981; 44:38–40.
28.
JohnsonGGMorrisJMBerkRS.The extracellular protease from Pseudomonas aeruginosa exhibiting elastase activity. Can J Microbiol1967; 13:711–720.
29.
CrossASSadoffJCIglewskiBHSokolPA.Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aearuginosa in humans. J Infect Dis1980; 142:538–546.
30.
SchwarzmannSBoringJRIII.Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect Immun1971; 3: 762–767.
31.
ScharmannWJacobFPorstenorferJ.The cytotoxic action of leucocidin from Pseudomonas aeruginosa on human polymorphonuclear leucocytes. J Gen Microbiol197693: 303–308.
32.
TosiMFZakemHBergerM.Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest199086: 300–308.
33.
BishopJFSchimpffSCDiggsCHWiernikPH.Infections during intensive chemotherapy for non-Hodgkin's lymphoma. Ann Intern Med1981; 95:549–555.
ForknerCEFreiEEdgeombJHUtzJP.Pseudomonas septicemia: observations on twenty-three cases. Am J Med1958; 25:877–889.
36.
CurtinJAPetersdorfRGBennettIL.Pseudomonas bacteremia: review of ninety-one cases. Ann Intern Med1961; 54:1077–1107.
37.
AndersonRJSchaferLAOlinDBEickhoffTC.Septicemia in renal transplant recipients. Arch Surg1973, 106: 692–694.
38.
KorvickJAMarshJWStarzlTEYuVL.Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery1991; 109:62–68.
39.
WhimbeyEKiehnTEBrannonPBacteremia and fungemia in patients with neoplastic disease. Am J Med1987; 82:723–730.
40.
CooperGSHavlirDSShlaesDMSalataRA.Polymicrobial bacteremia in the late 1980's: predictors of outcome and review of the literature. Medicine199069: 114–123.
41.
EltingLSBodeyGPFainsteinV.Polymicrobial septicemia in the cancer patient. Medicine198665: 218–225.
42.
GallagherPGWatanakunakornC.Pseudomonas bacteremia in a community teaching hospital, 1980–1984. Rev Infect Dis1989; 11:846–852.
43.
JohansonWGPierceAKSanfordJPThomasGD.Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med1972; 77:701–706.
44.
FlickMRGuffLE.Pseudomonas bacteremia: review of 108 cases. Am J Med197660: 501–508.
45.
ParkerMMFinkMP. Septic shock. J Intensive Care Med1992; 7: 90–100.
46.
KregerBECravenDEMcCabeWR.Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med1980; 68:344–355.
47.
WhitecarJPLunaMBodeyGP.Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sei1970260: 216–223.
48.
BaltchALGriffinPE.Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sei1977; 274:119–129.
49.
FishmanLSArmstrongD.Pseudomonas aeruginosa bacteremia in patients with neoplastic disease. Cancer1972; 30:764–773.
50.
DorffGJGeimerNFRosenthalDRRytelMW.Pseudomonas septicemia: illustrated evolution of its skin lesion. Arch InternMed1971; 128:591–595.
51.
GreeneSLSuWPDMullerSA.Ecthyma gangrenosum: report of clinical, histopathologic and bacteriologic aspects of eight cases. J Am Acad Dermatol198411: 781–787.
52.
TeplitzC.Pathogenesis of Pseudomonas vasculitis and septic lesions. Arch Pathol1965; 80:297–307.
53.
BarkerLF.The clinical symptoms, bacteriologie findings and postmortem appearances in cases of infection of human beings with the Bacillus pyocyaneus. JAMA1897; 29:213–216.
54.
FineJDMillerJAHarristTJHaynesHA.Cutaneous lesions in disseminated Candidiasis mimicking ecthyma gangrenosum. Am J Med1981; 70:1133–1135.
55.
RajanRK.Spontaneous bacterial peritonitis with ecthyma gangrenosum due to Escberichia coli. J Clin Gastroenterol1982; 4:145–148.
56.
RobertsRTarpayMMMarksMINitschkeR.Erysipelaslike lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis. JAMA1982; 248:2156–2157.
57.
BagelJGrossmanME.Subcutaneous nodules in Pseudomonas sepsis. Am J Med1986; 80:528–529.
58.
ReedRKLarterWESieberOFJohnTJ.Peripheral nodular lesions in Pseudomonas sepsis: the importance of incision and drainage. J Pediatr1976; 88:977–979.
59.
SchlossbergD.Multiple erythematous nodules as a manifestation of Pseudomonas aeruginosa septicemia. Arch Dermatol1980; 116:446–447.
60.
HallJHCallawayJLTindallJPSmithJG.Pseudomonas aeruginosa in dermatology. Arch Dermatol1968; 97: 312–323.
61.
KorvickJAYuVL.Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother1991; 35:2167–2172.
62.
AndrioleVT.Synergy of carbenicillin and gentamicin in experimental infection with Pseudomonas. J Infect Dis1971, 124 (suppl):S46–S55.
63.
AndrioleVT.Antibiotic synergy in experimental infection with Pseudomonas II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J Infect Dis1974; 129:124–133.
64.
HilfMYuVLSharpJAntibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med1989; 87:540–546.
65.
KlasterskyJCappelRDaneauD.Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer197331: 331–336.
66.
The EORTC International Antimicrobial Therapy Cooperative Group.Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med1987317: 1692–1698.
67.
PizzoPAHathornJWHiemenzJA randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med1986315: 552–558.
68.
WadeJC.Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy. Rev Infect Dis1989, 11 (suppl 7):S1572–S1581.
69.
MeunierFZinnerSHGayaHProspective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. Antimicrob Agents Chemother1991; 35:873–878.
70.
QuinnJPDudekEJDiVincenzoCAEmergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis1986; 154:289–294.
71.
EngRHKSmithSMCherubinCE.In-vitro emergence of beta-Iactam resistant variants of Pseudomonas aeruginosa. J Antimicrob Chemother1986; 17:717–723.
72.
AubertGPozzettoBDorcheG.Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. J Antimicrob Chemother1992; 29:307–312.
73.
TapperMLArmstrongD.Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report. J Infect Dis1974130(suppl):Sl4–S23.
74.
BisbeJGateilJMPuigJPseudomonas aearuginosa bacteremia: univariate and multivariate analysis of factors influencing the prognosis in 133 episodes. Rev Infect Dis1988; 10:629–635.
75.
BaltchGLHammerMSmithRPSutphenN.Pseudomonas aeruginosa bacteremia: susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance. J Lab Clin Med1979; 94:201–214.
76.
SaroffALArmstrongDJohnsonWD.Pseudomonas endocarditis. Am J Cardiol1973; 32:234–237.
77.
CohenPSMaguireJHWeinsteinL.Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. Prog Cardiovasc Dis1980; 22:205–242.
78.
ShekarRRiceTWZierdtCHKallickCA.Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype 011 among pentazocine and tripelennamine abusers in Chicago. J Infect Dis1985; 151:203–208.
79.
WielandMLedermanMMKline-KingCLeft-sided endocarditis due to Pseudomonas aeruginosa: a report of 10 cases and review of the literature. Medicine1986; 65:180–189.
80.
BotsfordKBWeinsteinRANathanCRKabinsSA.Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype 011 from drug addicts. J Infect Dis1985; 151:209–216.
81.
ReyesMPPalutkeWAWylinFLernerAM.Pseudomonas endocarditis in the Detroit Medical Center 1969–1972. Medicine1973; 52:173–194.
82.
RajashekaraiahKRRiceTWKallickCA.Recovery of Pseudomonas aeruginosa from syringes of drug addicts with endocarditis. J Infect Dis1981144:482.
83.
LevineDPCraneLRZervosMJ.Bacteremia in narcotic addicts at the Detroit Medical Center II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis1986; 8:374–396.
84.
ReyesMPLernerAM.Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis1983; 5:314–321.
85.
BayerASBlomquistIKKimKS.Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. J Antimicrob Chemother1986; 17:641–649.
86.
RobinEBelamaricJThomsNWConsequences of total tricuspid valvulectomy without prosthetic replacement in treatment of Pseudomonas endocarditis. J Thorac Cardiovasc Surg1974; 68:461–465.
87.
Jimenez-LuchoVESaravolatzLDMedeirosAAPohlodD.Failure of therapy in Pseudomonas endocarditis: selection of resistant mutants. J Infect Dis1986; 154:64–68.
88.
MyerowitzPDGardnerPCampbellCEarlier operation for left-sided Pseudomonas endocarditis in drug addicts. J Thorac Cardiovasc Surg1979; 77:577–581.
89.
CravenDEStegerKABaratLMDuncanRA.Nosocomial pneumonia: epidemiology and infection control. Intensive Care Med199218:S3–S9.
90.
RoseHDHeckmanMGUngerJD.Pseudomonas pneumonia in adults. Am Rev Respir Dis1973107: 416–422.
91.
RubioTT.Infection in patients with cystic fibrosis. Am J Med1986, 81 (suppl lA):73–77.
92.
StevensRMTeresDSkillmanJJFeingoldDS.Pneumonia in an intensive care unit: a 30-month experience. Arch Intern Med1974; 134:106–111.
93.
GriebleHGColtonFRBirdTJFine-panicle humidifiers; source of Pseudomonas aeruginosa infections in a respiratory-disease unit. N Engl J Med1970; 282:531–535.
TillotsonJRLernerAM.Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med1968; 68: 295–306.
96.
PenningtonJEReynoldsHYCarbonePP.Pseudomonas pneumonia: a retrospective study of 36 cases. Am J Med1973; 55:155–160.
97.
BurnsMW.Significance of Pseudomonas aeruginosa in sputum. Br Med J1973; 3:382–383.
98.
FetzerAEWernerASHagstromJWC.Pathologic features of Pseudomonal pneumonia. Am Rev Respir Dis1967; 96:1121–1130.
99.
SoaveRMurrayHWLitrentaMM.Bacterial invasion of pulmonary vessels: Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am J Med1978; 65:864–867.
100.
SerraPHoppesWL.Metastatic tumor and Pseudomonas: problems of diagnosis and management. Chest1977; 71:70–75.
101.
UnertlKELenhartFPForstHPeterK.Systemicantibiotic treatment of nosocomial pneumonia. Intensive Care Med1992; 18:S28–S34.
102.
CelisRTorresAGateilJMNosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest1988; 93:318–324.
103.
KlickJMDu MoulinGCHedley-WhyteJPrevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis: II. Effect on the incidence of pneumonia in seriously ill patients. J Clin Invest1975; 55: 514–519.
104.
FeeleyTWDu MoulinGCHedley-WhyteJAerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med1975; 293:471–475.
105.
ChartrandSAMarksMI.Pulmonary infections in cystic fibrosis: pathogenesis and therapy. In: PenningtonJE, ed. Respiratory infections: diagnosis and management. New York: Raven, 1989:276–297.
106.
ChernikNLArmstrongDPosnerJB.Central nervous system infections in patients with cancer. Medicine197352: 563–581.
107.
WiseBLMathisJLJawetzE.Infections of the central nervous system due to Pseudomonas aeruginosa. J Neurosurg196931: 432–434.
108.
FongIWTomkinsKB.Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime. Rev Infect Dis1985; 7:604–612.
109.
BerkSLMcCabeWR.Meningitis caused by gram-negative bacilli. Ann Intern Med1980; 93:253–260.
110.
TurgeonPLLaverdiereMPerronL.Successful treatment of Pseudomonas meningitis and septicemia in a leukemic neutropenic adult. Am J Clin Pafhol197563: 135–141.
111.
SwartzMN.Intraventricular use of aminoglycosides in the treatment of gram negative bacillary meningitis: conflicting views. J Infect Dis1981; 143:293–296.
112.
ChunCHJohmsonJDHofstetterMRaffMJ.Brain abscess: a study of 45 consecutive cases. Medicine198665: 415–431.
KuninCM.A ten-year study of bacteriuria in schoolgirls: final report of bacteriologic, urologic, and epidemiologic findings. J Infect Dis1970; 122:382–393.
115.
MontgomerieJZMorrowJ.Long-term Pseudomonas colonization in spinal cord injury patients. Am J Epidemiol1980; 112:508–517.
116.
WiessemanGJWoodVEKrollLL.Pseudomonas vertebral osteomyelitis in heroin addicts: report of five cases. J Bone Joint Surg [Am]1973; 55:1416–1424.
117.
YangECNeuwirthMG.Pseudomonas aeruginosa as a causative agent of cervical osteomyelitis: case report and review of the literature. Clin Orthop1988; 231:229–233.
118.
WatanakunakornC.Vertebral osteomyelitis as a complication of Pseudomonas aeruginosa pneumonia. South Med J1975; 68:173–176.
119.
McHenryMCRehmSJKrajewskiLPVertebral osteomyelitis and aortic lesions: case report and review. Rev Infect Dis1991; 13:1184–1194.
120.
NordenCWKeletiE.Experimental osteomyelitis caused by Pseudomonas aeruginosa. J Infect Dis1980; 141:71–75.
121.
TindelJRCrowderJG.Septic arthritis due to Pseudomonas aeruginosa. JAMA1971; 218:559–561.
122.
SapicoFLMontgomerieJZ.Vertebral osteomyelitis in intravenous drug abusers: report of three cases and review of the literature. Rev Infect Dis1980; 2:196–206.
SequeiraWJonesESiegelMEPyogenic infections of the pubic symphysis. Ann Intern Med1982; 96:604–606.
125.
BayerASChowAWLouieJSGuzeLB.Sternoarticular pyoarthrosis due to gram-negative bacilli: report of eight cases. Arch Intern Med1977; 137:1036–1040.
126.
GrobmanLRGanzWCasianoRGoldbergS.Atypical osteomyelitis of the skull base. Laryngoscope1989; 99:671–676.
127.
GiffordDBPatzakisMIvlerDSwezeyRL.Septic arthritis due to Pseudomonas in heroin addicts. J Bone Joint Surg [Am]1975; 57:631–635.
128.
BachMCCoccchettoDM.Ceftazidime as single-agent therapy for Gram-negative aerobic bacillary osteomyelitis. Anti-microb Agents Chemother1987; 31:1605–1608.
129.
HessenMTIngermanMJKaufmanDHClinical efficacy of ciprofloxacin therapy for Gram-negative bacillary osteomyelitis. Am J Med1987, 82 (suppl 4A):262–265.
130.
FlormanALSchifrinN.Observations on a small outbreak of infantile diarrhea associated with Pseudomonas aeruginosa. J Pediatr1950; 36:758–766.
131.
StoneHHKolbLDGeheberCE.Bacteriologic considerations in perforated necrotizing enterocolitis. South Med J1979; 72:1540–1544.
132.
AmrominGDSolomonRD.Necrotizing enteropathy: a complication of treated leukemia or lymphoma patients. JAMA1962; 182:133–139.
133.
StarnesHFJrMooreFDJrMentzerSAbdominal pain in neutropenic cancer patients. Cancer1986; 57: 616–621.
134.
AltBGlassNRSollingerH.Neutropenic enterocolitis in adults: review of the literature and assessment of surgical intervention. Am J Surg1985; 149:405–408.
135.
ShermanNJWoolleyMM.The ileocecal syndrome in acute childhood leukemia. Arch Surg1973; 107:39–42.
136.
SchimpffSCWiernikPHBlockJB.Rectal abscesses in cancer patients. Lancet1972; 2:844–847.
137.
ShakedAAShinarEFreundH.Managing the granulocytopenic patient with acute perianal inflammatory disease. Am J Surg1986; 152:510–512.
138.
ClassenDCJacobsonJABurkeJPSerious Pseudomonas infections associated with endoscopic retrograde cholangiopancreatography. Am J Med1988; 84:590–596.
139.
DavionTBraillonADelamarreJPseudomonas aeruginosa liver abscesses following endoscopic retrograde cholangiography: report of a case without biliary tract disease. Dig Dis Sei1987; 32:1044–1046.
140.
AllenJIAllenMOOlsonMMPseudomonas infection of the biliary system resulting from use of a contaminated endoscope. Gastroenterology1987; 92:759–763.
141.
BassDHOliverSBornmanPC.Pseudomonas septicaemia after endoscopie retrograde cholangiopancreatography—an unresolved problem. S Afr Med J1990; 77:509–511.
142.
O'ConnorHJBabbJRAyliffeGAJ.Pseudomonas aeruginosa infection during endoscopy. Gastroenterology1987; 93:1451.
143.
KusneSEiblingDEYuVLGangrenous cellulitis associated with gram-negative bacilli in pancytopenic patients: dilemma with respect to effective therapy. Am J Med1988; 85:490–494.
144.
KoopmannCFJrCoulthardSW.Infectious facial and nasal cutaneous necrosis: evaluation and diagnosis. Laryngoscope1982; 92:1130–1134.
145.
BergAArmitageJOBurnsCP.Fournier's gangrene complicating aggressive therapy for hematologic malignancy. Cancer1986; 57:2291–2294.
146.
ManianFAAlfordRH.Nosocomial infectious balanoposthitis in neutropenic patients. South Med J1987; 80:909–911.
147.
Siegman-IgraYShafirRWeissJSerious infectious complications of midsternotomy: a review of bacteriology and antimicrobial therapy. Scand J Infect Dis1990; 22:633–643.
HuminerDSiegman-IgraYMorduchowiczGPitlikSD.Ecthyma gangrenosum without bacteremia: report of six cases and review of the literature. Arch Intern Med1987; 147:299–301.
150.
BazePEThyssACaldaniCPseudomonas aeruginosa O-11 folliculiltis: development into ecthyma gangrenosum in immunosuppressed patients. Arch Dermatol1985; 121:873–876.
151.
KleinRSBergerSAYekutielP.Wound infection during the Yom Kippur War: observations concerning antibiotic prophylaxis and therapy. Ann Surg1975; 182:15–21.
152.
TongMJ.Septic complications of war wounds. JAMA1972; 219:1044–1047.
153.
AltemeierWA.Bacteriology of traumatic wounds. JAMA1944; 124:413–417.
154.
HeggersJPBarnesSTRobsonMCMicrobial flora of orthopaedic war wounds. Milit Med1969; 134:602–603.
155.
MatsumotoTWyteSRMoseleyRVCombat surgery' in communication zone I. War wound and bacteriology (preliminary report). Milit Med1969; 134:655–665.
156.
PruittBAJrLindbergRBMcManusWFMasonADJr.Current approach to prevention and treatment of Pseudomonas aeruginosa infections in burned patients. Rev Infect Dis1983, 5 (suppl 5):S889–S897.
157.
LutermanADascsoCCCurreriPW.Infeaions in burn patients. Am J Med1986, 81 (suppl 1A):45–52.
158.
HansbroughJFCarrollWBZapata-SirventRLIdentification and antibiotic susceptibility of bacterial isolates from burned patients. Burns Incl Therm Inj1985; 11:393–403.
159.
McManusATMasonADJrMcManusWFPruittBAJr.Twenty-five year review of Pseitclomonas aeruginosa bac-teremia in a burn center. Eur J Clin Microbiol1985; 4:219–223.
160.
ShiraniKZMcManusATVaughanG.MEffects of environment on infection in burn patients. Arch Surg1986; 121:31–36.
161.
McManusATMcManusWFMasonADJrMicrobial colonization in a new intensive care burn unit. Arch Surg1985; 120:217–223.
DoroghaziRMNadolJBJrHyslopNEJrInvasive external otitis: Report of 21 cases and review of the literature. Am J Med1981; 71:603–614.
174.
SutherlandGE.Malignant external otitis in a nondiabetic adult. South Med J1981; 74:516.
175.
ShermanPBlackSGrossmanM.Malignant external otitis due to Pseudomonas aeruginosa in childhood. Pediatrics1980; 66:782–783.
176.
RubinJYuVL.Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med1988; 85:391–398.
177.
ZakyDABentleyDWLowyKMalignant external otitis: a severe form of otitis in diabetic patients. Am J Med1976; 61:298–302.
178.
GheriniSGBrackmannDEBradleyWG.Magnetic resonance imaging and computerized tomography in malignant external otitis. Laryngoscope1986; 96:542–548.
179.
MeyersBRMendelsonMHParisierSCHirschmanSZ.Malignant external otitis: comparison of monotherapy vs combination therapy. Arch Otolaryngol Head Neck Surg1987; 113:974–978.
180.
JohnsonMPRamphalR.Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis. Rev Infect Dis1990; 12:173–180.
181.
LangRGoshenSKitzes-CohenRSadeJ.Successful treatment of malignant external otitis with oral ciprofloxacin: report of experience with 23 patients. J Infect Dis1990; 161:537–540.
JuergensenPHFinkelsteinFOBrennanRPseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study. Am J Kidney Dis1988; 11:413–417.
189.
PirainoBBernardiniJSorkinM.A five-year study of the microbiologie results of exit site infeaions and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis1987; 10:281–286.
190.
DresslerRPetersATLynnRI.Pseudomonal and Candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med1989; 86:787–790.
191.
ParrottPLTerryPMWhitworthENPseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet1982; 2:683–685.
192.
GoetzAMuderRR.Pseudomonas aeruginosa infections associated with use of povidone-iodine in patients receiving continuous ambulatory peritoneal dialysis. Infect Control Hosp Epidemiol1989; 10:447–450.
193.
BernardiniJPirainoBSorkinM.Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infeaions. Am J Med1987; 83:829–832.
194.
LaneHCDepperJMGreeneWCQualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a seleaive defea in soluble antigen recognition. N Engl J Med1985; 313:79–84.
195.
WittDJCravenDEMcCabeWR.Bacterial infeaions in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med1987; 82;900–906.
196.
KrumholzHMSandeMALoB.Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med1989; 86:776–779.
197.
ShansonDC.Septicaemia in patients with AIDS. Trans R Soc Trop Med Hyg1990, 84 (suppl 1):14–16.
198.
KrasinskiKBorkowskyWBonkSBacterial infeaions in human immunodeficiency virus-infeaed children. Pediatr Infea Dis J1988; 7:323–328.
199.
NicholsLBaloghKSilvermanM.Bacterial infections in the acquired immunodeficiency syndrome: clinicopathologic correlations in a series of autopsy cases. Am J Clin Pathol1989; 92:787–790.
200.
EngRHKLynchAMSmithSMImipenem resistance in a case of AIDS with relapsing Pseudomonas meningitis. South Med J1990; 83:979–980.
201.
Kowal-VernAMcFaddenJ.Pseudomonas aeruginosa pneumonia as a presenting entity in an AIDS patient. Clin Pediatr1989; 28:403.
202.
KielhofnerMAtmarRLHamillRJMusherDM.Life-threatening Pseudomonas aeruginosa infeaions in patients with human immunodeficiency virus infection. Clin Infect Dis1992; 14:403–411.
203.
ZieglerEJFisherCJJrSprungCLTreatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blinded, placebo-controlled trial. N Engl J Med1991; 324:429–436.
204.
GreenmanRLScheinRMHMartinMAA controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA1991; 266:1097–1102.
205.
WarrenHSDannerRLMunfordRS.Anti-endotoxin monoclonal antibodies. N Engl J Med1992; 326:1153–1157.
206.
WenzelRPAndrioleVTBartlettJGAntiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis1992; 14:973–976.
207.
CollinsHHCrossASDobekAOral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa. J Infect Dis1989; 159:1073–1082.
208.
YoungLSMeyerRDArmstrongD.Pseudomonas aeruginosa vaccine in cancer patients. Ann Intern Med1973; 79:518–527.
209.
CryzSJJrFurerECrossASSafety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. J Clin Invest1987; 80:51–56.
210.
CryzSJJrFurerESadoffJCProduction and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species. J Infect Dis1991; 163:1055–1061.
211.
CollinsMSLadehoffDKMehtonNSNoonanJS.Opsonic and protective activity of five human IgM monoclonal antibodies reactive with the lipopolysaccharide antigen of Pseudomonas aeruginosa. FEMS Microbiol Immunol1990; 2:263–268.
